Score Overview
See the full market ranking โ
Compass Therapeutics Inc. fundamental performance
Across Compass Therapeutics Inc.'s full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 82M to -$ 66M. Revenue increased in 20% of the years measured; net income in 20%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.37 | โ |
1 Year2025-08-12 | $ 3.17 | -25.24% |
5 Years2021-08-11 | $ 4.08 | -41.91% |
10 Years2006-02-24 | $ 8.36 | -71.65% |
20 Years2006-02-24 | $ 8.36 | -71.65% |
30 Years1996-08-12 | $ 3.56 | -33.47% |
All Time2021-04-05 | $ 8.50 | -72.12% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-11 | 10 Years2006-02-24 | 20 Years2006-02-24 | 30 Years1996-08-12 | All Time2021-04-05 |
|---|---|---|---|---|---|---|---|
| Price | $ 2.37 | $ 3.17 | $ 4.08 | $ 8.36 | $ 8.36 | $ 3.56 | $ 8.50 |
| Return | โ | -25.24% | -41.91% | -71.65% | -71.65% | -33.47% | -72.12% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 73M | $ 179M |
| 2025 | $ 0.00 | -$ 66M | $ 208M |
| 2024 | $ 850K | -$ 49M | $ 126M |
| 2023 | $ 0.00 | -$ 42M | $ 152M |
| 2022 | $ 0.00 | -$ 39M | $ 186M |
| IPO2021 | $ 0.00 | -$ 82M | $ 144M |
Explore beyond CMPX
You're looking at Compass Therapeutics Inc.. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.